Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06035679 |
|---|---|
| Brief Title: | Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer |
| First Submitted : | August 31, 2023 |
| First Submitted that Met QC Criteria : | September 11, 2023 |
| First Posted : | September 13, 2023 |
| Last Update Submitted that Met QC Criteria : | February 26, 2024 |
| Last Update Posted : | February 28, 2024 |